Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.

Antiviral therapy - 1 Jan 2010

Johannessen Asgeir, Holberg-Petersen Mona, Lövgaarden Gunilla, Naman Ezra, Ormaasen Vidar, Matee Mecky I, Gundersen Svein G, Bruun Johan N

Abstract excerpt

BACKGROUND: HIV type-1 (HIV-1) drug resistance testing is rarely available in resource-limited settings because of high costs and stringent requirements for storage and transport of plasma. Dried blood spots (DBS) can be a convenient alternative to plasma, but the use of DBS needs validation under field conditions. We assessed the performance of DBS in genotypic resistance testing of patients who failed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Genotype

Share to HIV Infections

Share to Mutation

Source

Identifiers

PMID: 21041915
DOI: 10.3851/IMP1660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.PMID 21041915Read ↗

HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.Semantic proximity Read ↗

Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.Semantic proximity Read ↗

Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.Semantic proximity Read ↗

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.Semantic proximity Read ↗

Genotypic testing for HIV-1 drug resistance using dried blood samples.Semantic proximity Read ↗

Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral TherapySemantic proximity Read ↗

A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.Semantic proximity Read ↗

HIV-2 Drug Resistance Genotyping from Dried Blood Spots.Semantic proximity Read ↗

HIV-1 drug mutations in children from northern Tanzania.Semantic proximity Read ↗

HIV-1 drug resistance surveillance using dried whole blood spots.Semantic proximity Read ↗

Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.Semantic proximity Read ↗

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.